ALISON STINNETT: Open Payments
NPI 1427066323 · POULSBO, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,793 in 81 payments from 15 companies in 2025. Trend: 2023 $979 · 2024 $715 · 2025 $1,793
Food & beverage: $1,634Education: $159
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 25 | $496 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 8 | $263 |
| Amgen Inc. | 12 | $144 |
| PFIZER INC. | 11 | $139 |
| Janssen Scientific Affairs, LLC | 1 | $118 |
| Novartis Pharmaceuticals Corporation | 5 | $116 |
| ABBVIE INC. | 4 | $112 |
| SANOFI-AVENTIS U.S. LLC | 1 | $92 |
| Incyte Corporation | 4 | $86 |
| Organogenesis Inc. | 3 | $68 |
Products named: TREMFYA, Cabtreo, DUPIXENT, OTEZLA, COSENTYX, SKYRIZI, CIBINQO, SILIQ.
Industry payments across WA — which companies pay providers there.
